Miami, Florida, USA
2ⁿᵈ Edition of the Cancer R&D World Conference 2026
Scientific Sessions
Emerging Biomarkers for Cancer Detection and Prognosis
Advancements in cancer research are unveiling a new generation of biomarkers that are transforming early detection and disease management. Molecular indicators found in blood, tissue, and other body fluids such as circulating tumor DNA, microRNAs, and exosomes provide deeper insights into tumor biology and patient response. These biomarkers enable non-invasive screening, precise disease monitoring, and improved prediction of treatment outcomes. Using integrated multi-omics technologies and artificial intelligence, subtle molecular changes signaling very early-stage cancer can now be detected.
This session focuses on discoveries of biomarkers, their validation, and clinical application. At the Cancer Research and Development Conference 2026, the experts will further discuss exactly how predictive and prognostic biomarkers are guiding personalized therapies, enhancing accuracy in diagnosis, and shaping the future of precision oncology. Join us to examine the ways in which emerging biomarkers continue to redefine cancer detection, prognosis, and patient-centered care.
Related Sessions
We, the Precision Global Conferences, welcome all the students, scholars, researche ...
Read More>>
